(Q43167215)

English

In vitro and in vivo effects of UP 269-6, a new potent orally active nonpeptide angiotensin II receptor antagonist, on vascular smooth muscle cell proliferation

scientific article published in February 1997

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

15 November 2017

In vitro and in vivo effects of UP 269-6, a new potent orally active nonpeptide angiotensin II receptor antagonist, on vascular smooth muscle cell proliferation (English)

1 reference

Europe PubMed Central

PMC publication ID

15 November 2017

author name string

A Virone-Oddos

1

1 reference

Europe PubMed Central

PMC publication ID

15 November 2017

V Desangle

2

1 reference

Europe PubMed Central

PMC publication ID

15 November 2017

D Provost

3

1 reference

Europe PubMed Central

PMC publication ID

15 November 2017

M Cazes

4

1 reference

Europe PubMed Central

PMC publication ID

15 November 2017

F Caussade

5

1 reference

Europe PubMed Central

PMC publication ID

15 November 2017

A Cloarec

6

1 reference

Europe PubMed Central

PMC publication ID

15 November 2017

language of work or name

0 references

publication date

1 February 1997

1 reference

Europe PubMed Central

PMC publication ID

15 November 2017

British Journal of Pharmacology

1 reference

Europe PubMed Central

PMC publication ID

15 November 2017

120

1 reference

Europe PubMed Central

PMC publication ID

15 November 2017

3

1 reference

Europe PubMed Central

PMC publication ID

15 November 2017

488-494

1 reference

Europe PubMed Central

PMC publication ID

15 November 2017

Angiotensin II-stimulated protein synthesis in cultured vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0700897

21 January 2018

BMS-180560, an insurmountable inhibitor of angiotensin II-stimulated responses: comparison with losartan and EXP3174.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0700897

21 January 2018

Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0700897

21 January 2018

Influence of blood pressure on development of aortic medial smooth muscle hypertrophy in spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0700897

21 January 2018

Responses of subcultured rat aortic smooth muscle myocytes to vasoactive agents and KCl-induced depolarization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0700897

7 January 2021

based on heuristic

inferred from DOI database lookup

Receptor-mediated effects of angiotensin II on growth of vascular smooth muscle cells from spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0700897

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro pharmacological characterization of UP 269‐6, a novel nonpeptide angiotensin II receptor antagonist

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0700897

7 January 2021

based on heuristic

inferred from DOI database lookup

In vivo pharmacological characterization of UP 269-6, a novel nonpeptide angiotensin II receptor antagonist

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0700897

7 January 2021

based on heuristic

inferred from DOI database lookup

Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0700897

7 January 2021

based on heuristic

inferred from DOI database lookup

Abnormalities in growth characteristics of aortic smooth muscle cells in spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0700897

7 January 2021

based on heuristic

inferred from DOI database lookup

Differences in mitogenic responses to angiotensin II, calf serum and phorbol ester in vascular smooth muscle cells from two strains of genetically hypertensive rat.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0700897

7 January 2021

based on heuristic

inferred from DOI database lookup

Rat angiotensin II receptor: cDNA sequence and regulation of the gene expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0700897

7 January 2021

based on heuristic

inferred from DOI database lookup

Peptide growth factors markedly decrease the ligand binding of angiotensin II type 2 receptor in rat cultured vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0700897

7 January 2021

based on heuristic

inferred from DOI database lookup

Losartan, a nonpeptide angiotensin II (Ang II) receptor antagonist, inhibits neointima formation following balloon injury to rat carotid arteries

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0700897

7 January 2021

based on heuristic

inferred from DOI database lookup

A practical computer-based approach to the analysis of radioligand binding experiments

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0700897

7 January 2021

based on heuristic

inferred from DOI database lookup

Analysis of radioligand binding experiments. A collection of computer programs for the IBM PC.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0700897

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of angiotensins on cellular hypertrophy and c-fos expression in cultured arterial smooth muscle cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0700897

7 January 2021

based on heuristic

inferred from DOI database lookup

Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0700897

7 January 2021

based on heuristic

inferred from DOI database lookup

Synthesis and SAR studies of novel triazolopyrimidine derivatives as potent, orally active angiotensin II receptor antagonists

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0700897

7 January 2021

based on heuristic

inferred from DOI database lookup

Angiotensin II-induced proliferation of aortic myocytes in spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0700897

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0700897

7 January 2021

based on heuristic

inferred from DOI database lookup

The proliferative response to vascular injury is suppressed by angiotensin-converting enzyme inhibition

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0700897

7 January 2021

based on heuristic

inferred from DOI database lookup

Suppression of the vascular response to injury: the role of angiotensin-converting enzyme inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0700897

7 January 2021

based on heuristic

inferred from DOI database lookup

EXP3174, a metabolite of losartan (MK954, DuP753) is more potent than losartan in blocking the angiotensin ll-induced responses in vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0700897

7 January 2021

based on heuristic

inferred from DOI database lookup

Cloning and expression of a complementary DNA encoding a bovine adrenal angiotensin II type-1 receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0700897

7 January 2021

based on heuristic

inferred from DOI database lookup

Angiotensin II induces delayed mitogenesis and cellular proliferation in rat aortic smooth muscle cells. Correlation with the expression of specific endogenous growth factors and reversal by suramin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0700897

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.BJP.0700897

1 reference

Europe PubMed Central

PMC publication ID

15 November 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

15 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

15 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43167215&oldid=1982770025"